263713-26-4

Basic information

• Product Name: N,N’-(1,4-phenylenebis(methylene))bis(1-(pyridin-2-yl)-N-(pyridin-2-ylmethyl)methanamine)
• Synonyms: N,N’-(1,4-phenylenebis(methylene))bis(1-(pyridin-2-yl)-N-(pyridin-2-ylmethyl)methanamine)
• CAS NO: 263713-26-4
• Molecular Weight: 500.646
• Mol File: 263713-26-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: N,N’-(1,4-phenylenebis(methylene))bis(1-(pyridin-2-yl)-N-(pyridin-2-ylmethyl)methanamine)(CAS DataBase Reference)
• NIST Chemistry Reference: N,N’-(1,4-phenylenebis(methylene))bis(1-(pyridin-2-yl)-N-(pyridin-2-ylmethyl)methanamine)(263713-26-4)
• EPA Substance Registry System: N,N’-(1,4-phenylenebis(methylene))bis(1-(pyridin-2-yl)-N-(pyridin-2-ylmethyl)methanamine)(263713-26-4)

Safety Data

• Hazardous Substances Data: 263713-26-4(Hazardous Substances Data)

Upstream product

• 1539-42-0 bis[(2-pyridyl)methyl]amine 
• 1121-60-4 pyridine-2-carbaldehyde 
• 539-48-0 p-xylylidenediamine 
• 6959-47-3 2-chloromethylpyridine hydrochloride 
• 623-24-5 1,4-bis(bromomethyl)benzene 

Relevant articles and documents

Effective disruption of phosphoprotein-protein surface interaction using Zn(II) dipicolylamine-based artificial receptors via two-point interaction

Protein phosphorylation is ubiquitously involved in living cells, and it is one of the key events controlling protein-protein surface interactions, which are essential in signal transduction cascades. We now report that the small molecular receptors beari

NOVEL CXCR4 ANTAGONIST AND USE THEREOF

The present invention provides a novel CXCR4 antagonist and use thereof. The present invention provides a novel non-peptidic, low-molecular-weight CXCR4 antagonist using various aromatic compounds each containing a dipicolylamine-zinc complex. The present invention also provides use of the novel CXCR4 antagonist as an anti-HIV agent, a metastasis inhibitor for a malignant tumor, or a chronic rheumatoid arthritis treatment and/or prevention agent.